AXEVIL Capital

Inari Agriculture Stock Price, Valuation & IPO

Private company — Inari Agriculture is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Status source: AXEVIL investment team

$12.61 per share (AXEVIL consensus estimate)

Source: AXEVIL consensus of recent secondary transactions · as of 10 November 2026

Last round valuation: $2.2B

Source: Series G, January 2025, post-money

Total raised: >$720M

Data last updated: 10 November 2026

About Inari Agriculture

Gene editing of seeds: it uses AI to find the genes that drive yield, edits them in partners' best varieties and sells the improvements to seed companies. High Yield Designs soybeans target a yield gain of 7.5% or more; it has raised more than $720 million in total.

Inari was created in 2016 by the venture builder Flagship Pioneering, the same firm that founded Moderna. Its headquarters are in Cambridge, with a research station in West Lafayette in the middle of the U.S. corn and soybean belt, and a lab and greenhouses in Ghent, Belgium. Its SEEDesign platform uses machine learning to predict which genes affect yield and makes several edits to a plant's DNA at once without introducing foreign genes. The company has no seed production of its own: it sells the improvements to seed companies, and the seeds reach farmers under partners' brands. Its first finished product, High Yield Designs soybean varieties with a target yield gain of 7.5% or more, was tested across all U.S. soybean regions in summer 2025. Three crops are in development: soybeans, corn and wheat. It has raised more than $720 million in total, at a last valuation of $2.17 billion.

  • Sector: AgTech
  • Headquarters: Cambridge, USA
  • Founded: 2016

Key highlights

  1. M.S. Technologies: first to bring edited soybeans to market. Since 2021 the partnership has given Inari access to soybean varieties from the Stine breeding program, one of the leading programs in the U.S. M.S. Technologies will be the first company to offer farmers seeds with High Yield Designs.
  2. InterGrain: wheat in five fields in Australia. In 2024 InterGrain imported several thousand Inari wheat seeds, and in 2025 it grew them in five trial fields. The intended changes were confirmed, and in 2026 the trials are expanding to the state of Victoria.
  3. Corteva: dispute closed with a settlement. In 2023 Corteva accused Inari of using its corn and soybean lines from the ATCC collection. In September 2026 the parties reached a settlement: Inari will transfer to Corteva the rights to edited versions of Corteva's transgenic traits, and licenses are being negotiated separately.

Frequently asked questions

How can I buy Inari Agriculture stock before the IPO?

Not on a public exchange — Inari Agriculture is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

What is the Inari Agriculture stock price?

A private company has no single official share price. AXEVIL's consensus estimate is $12.61 per share as of 10 November 2026. Its most recent round implied a post-money valuation of $2.2B (January 2025).

What is Inari Agriculture's valuation (net worth)?

Inari Agriculture's most recent funding round valued the company at $2.2B post-money (January 2025) — the latest primary-market measure of what the company is worth. Secondary trades can price its shares above or below that round.

When will Inari Agriculture IPO?

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

Is Inari Agriculture publicly traded?

No. Inari Agriculture is a private company and its shares are not listed on any public exchange.

Does Inari Agriculture have a stock symbol?

No. Inari Agriculture has no ticker symbol because its shares are not listed on any exchange; a symbol is assigned only at an IPO or direct listing.

Similar companies

Risk disclosure

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Full legal disclosures · All companies